Growblox Sciences Inc (GBLX) 0.3250 $GBLX
GrowBLOX Sciences, Inc. Announces Exclusive Rights To Kyle Kushman's Cannabis Brands, Strains And Genetics In The State Of Nevada
PR Newswire - Tue Jun 07, 8:48AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announces the execution of an agreement with Kyle Kushman, Kushman Brands and Genetics LLC, and its affiliate Karma Consulting (collectively, "Kushman"
. Pursuant to the agreement, GrowBLOX and its subsidiary GB Sciences Nevada, LLC (dba "Cultivation Labs" will have exclusive rights in Nevada to Kushman's cannabis brands, strains and genetics. Kushman also will advise GB Sciences' Cultivation Labs on the expansion of its cannabis cultivation facility in Las Vegas, as well as operating processes and procedures based on Kushman's methods and unique Veganic growing techniques.
GrowBLOX Granted Occupancy Permit for Las Vegas Cannabis Cultivation Facility
PR Newswire - Mon May 23, 8:30AM CDT
GrowBLOX Sciences, Inc., (OTCQB: GBLX) announced today that it was granted an occupancy permit for its 28,000 sf. Cannabis cultivation facility at 3550 West Teco Ave in Las Vegas, Clark County, Nevada.
Growblox Sciences Adds Leslie Bocskor, founder and President of Electrum Partners, Shane Terry, Former President of the Nevada Dispensary Association and John Poss, Current President and CFO of Growblox Sciences to the Company's Board of Directors
PR Newswire - Tue May 03, 3:15PM CDT
Growblox Sciences, Inc. (OTCQB: GBLX) has added three experienced and accomplished executives in the cannabis industry to its board of directors as part of management changes designed to build cash flow with a focus on innovative cultivation operations and maximizing the company's scientific advancements and drug discovery efforts that will lead to game-changing cannabis based pharmaceutical compounds.
DigiPath (DIGP) Builds Revenue in Attractive Nevada Market
ACCESSWIRE - Mon Apr 25, 8:45AM CDT
SEATTLE, WA / ACCESSWIRE / April 25, 2016 / The marijuana industry is rapidly growing throughout the United States and could reach $35 billion in size by 2020, with Nevada representing one of the country's hottest markets. With recreational legalization on the November ballot, the state has the potential to replace Colorado as a leading marijuana tourism destination. It could even become a global destination for cannabis alongside cities like Amsterdam.
GrowBLOX Sciences Announces Key Executive Appointments
PR Newswire - Tue Jan 05, 8:00AM CST
GrowBLOX Sciences, Inc., (OTCQB: GBLX), The Company is proud to announce the appointment of Mr. John Poss as its President and Chief Operating Officer. John joined the Company earlier this year as a consultant, and became Chief Financial Officer during the summer, and, as was previously announced, has extensive executive experience in both finance and operations for an enviable group of industrial enterprises, both large and small. For the moment, Mr. Poss will retain both the chief operating and chief financial titles.
GrowBLOX Sciences Annual Letter To Shareholders
PR Newswire - Mon Jan 04, 8:00AM CST
GrowBLOX Sciences, Inc., (OTCQB: GBLX),
Cabinet Grow: Real Revenue, Real Potential
ACCESSWIRE - Tue Nov 03, 8:20AM CST
SEATTLE, WA / ACCESSWIRE / November 3, 2015 / The U.S. cannabis industry could be worth $35 billion by 2020, according to GreenWave Advisors, if the federal government ended prohibition. In a more conservative model, the analyst believes that the market could still exceed $20 billion, with 12 states and Washington DC legalizing adult-use cannabis and 37 states legalizing medical marijuana. The rapid growth and scale comes from a combination of state programs and home-grow legalization initiatives.
GrowBLOX Sciences Announces Patent Filings for Its Proprietary Process to Create Uniform Reproducible Cannabis Extracts
ACCESSWIRE - Tue Oct 13, 8:01AM CDT
GBLX Staying at the Forefront of Medical Cannabis Technology
GrowBLOX Sciences Announces First of Four Cultivation Labs Scheduled to Open in Las Vegas
ACCESSWIRE - Mon Sep 28, 8:02AM CDT
Expected to Open by End of Fourth Quarter; $10-12 Million Annual Revenue at Full Capacity at Just This Facility; Cutting-Edge Technological Growing of Medical Grade Cannabis
GrowBLOX Sciences Secures Four New Nevada State Medical Cannabis Licenses
ACCESSWIRE - Wed Sep 16, 8:01AM CDT
Continues to Accelerate its Plans for Significant Revenue Growth in 2016
GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General Manager
ACCESSWIRE - Tue Sep 08, 8:01AM CDT
Continues the Development of a Formidable GBLX Executive Team
GrowBLOX Sciences Appoints New CFO John Poss
ACCESSWIRE - Tue Aug 25, 7:30AM CDT
Creating a Formidable Executive Team
GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
GlobeNewswire - Thu Jul 23, 1:17PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced that over the course of the next few weeks certain changes in management personnel and operating procedures would soon be implemented in preparation for the commencement of cultivation operations through our majority-owned subsidiary, GB Sciences Nevada, LLC.
DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market
ACCESSWIRE - Thu Jul 16, 8:00AM CDT
WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.'s (OTCQB: GBLX) growing solutions to Medbox Inc.'s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.'s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.
These Cannabis Stocks Are Heating Up This Summer, 2015
ACCESSWIRE - Tue Jun 16, 3:07PM CDT
CORAL GABLES, FL / ACCESSWIRE / June 16, 2015 / More states are jumping on board the cannabis train and this industry has certainly begun to evolve since Colorado first came online as America's original legal state. Despite the recent uproar concerning the decision for business owners not to condone cannabis use (medical or otherwise), the market continues to take a liking to this industry because it is, in fact, just beginning to blossom. Aside from popular belief, this space isn't full of growers alone, there is an entire economy growing around the idea. Businesses are sprouting up with ideas from anything like cannabis vacation destinations to hemp infused beverages and anything in between. Companies like FBEC Worldwide (PINKSHEETS: FBEC), the Maryjane Group (OTCQB: MJMJ) and GrowBLOX Sciences, Inc. (OTCQB: GBLX) have all begun to see interest building around their novel concepts.
GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
GlobeNewswire - Mon Jun 15, 10:51AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced here today that it has received a $1.75 million funding commitment to enable GrowBLOX to complete construction and set-up operations at their MME Cultivation Facility in Las Vegas, Nevada. Pacific Leaf Ventures, LP has provided both the capital infusion and a license for their intellectual property including recognizable brand-names of cannabis and proprietary know-how for cultivation and cannabis extractions.
GrowBLOX Announces Deployment of Commercial Units
GlobeNewswire - Tue May 26, 12:29PM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the receipt of production-model GrowBLOX(TM) units for both GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR).
GROWBlox Sciences Takes Integrated Approach to Cannabis Medicine
ACCESSWIRE - Mon May 25, 7:36PM CDT
Untitled Document
GWPH: 83.28 (-0.88), GNC: 19.98 (+0.15), DGX: 84.91 (-0.27), NUTR: 25.46 (-0.05), LH: 138.05 (-0.66)
Growblox Announces Commercialization Initiative and Financing
GlobeNewswire - Wed May 13, 7:00AM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR", a majority-owned subsidiary domiciled in Puerto Rico.
Growblox Sciences Announces Launch of New Corporate Website
GlobeNewswire - Mon May 11, 11:21AM CDT
Growblox Sciences Inc. (OTCQB:GBLX) ("Growblox" or the "Company", a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the launch of its new corporate website.
GrowBLOX Sciences, Inc. Announces Exclusive Rights To Kyle Kushman's Cannabis Brands, Strains And Genetics In The State Of Nevada
PR Newswire - Tue Jun 07, 8:48AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announces the execution of an agreement with Kyle Kushman, Kushman Brands and Genetics LLC, and its affiliate Karma Consulting (collectively, "Kushman"
. Pursuant to the agreement, GrowBLOX and its subsidiary GB Sciences Nevada, LLC (dba "Cultivation Labs" will have exclusive rights in Nevada to Kushman's cannabis brands, strains and genetics. Kushman also will advise GB Sciences' Cultivation Labs on the expansion of its cannabis cultivation facility in Las Vegas, as well as operating processes and procedures based on Kushman's methods and unique Veganic growing techniques. GrowBLOX Granted Occupancy Permit for Las Vegas Cannabis Cultivation Facility
PR Newswire - Mon May 23, 8:30AM CDT
GrowBLOX Sciences, Inc., (OTCQB: GBLX) announced today that it was granted an occupancy permit for its 28,000 sf. Cannabis cultivation facility at 3550 West Teco Ave in Las Vegas, Clark County, Nevada.
Growblox Sciences Adds Leslie Bocskor, founder and President of Electrum Partners, Shane Terry, Former President of the Nevada Dispensary Association and John Poss, Current President and CFO of Growblox Sciences to the Company's Board of Directors
PR Newswire - Tue May 03, 3:15PM CDT
Growblox Sciences, Inc. (OTCQB: GBLX) has added three experienced and accomplished executives in the cannabis industry to its board of directors as part of management changes designed to build cash flow with a focus on innovative cultivation operations and maximizing the company's scientific advancements and drug discovery efforts that will lead to game-changing cannabis based pharmaceutical compounds.
DigiPath (DIGP) Builds Revenue in Attractive Nevada Market
ACCESSWIRE - Mon Apr 25, 8:45AM CDT
SEATTLE, WA / ACCESSWIRE / April 25, 2016 / The marijuana industry is rapidly growing throughout the United States and could reach $35 billion in size by 2020, with Nevada representing one of the country's hottest markets. With recreational legalization on the November ballot, the state has the potential to replace Colorado as a leading marijuana tourism destination. It could even become a global destination for cannabis alongside cities like Amsterdam.
GrowBLOX Sciences Announces Key Executive Appointments
PR Newswire - Tue Jan 05, 8:00AM CST
GrowBLOX Sciences, Inc., (OTCQB: GBLX), The Company is proud to announce the appointment of Mr. John Poss as its President and Chief Operating Officer. John joined the Company earlier this year as a consultant, and became Chief Financial Officer during the summer, and, as was previously announced, has extensive executive experience in both finance and operations for an enviable group of industrial enterprises, both large and small. For the moment, Mr. Poss will retain both the chief operating and chief financial titles.
GrowBLOX Sciences Annual Letter To Shareholders
PR Newswire - Mon Jan 04, 8:00AM CST
GrowBLOX Sciences, Inc., (OTCQB: GBLX),
Cabinet Grow: Real Revenue, Real Potential
ACCESSWIRE - Tue Nov 03, 8:20AM CST
SEATTLE, WA / ACCESSWIRE / November 3, 2015 / The U.S. cannabis industry could be worth $35 billion by 2020, according to GreenWave Advisors, if the federal government ended prohibition. In a more conservative model, the analyst believes that the market could still exceed $20 billion, with 12 states and Washington DC legalizing adult-use cannabis and 37 states legalizing medical marijuana. The rapid growth and scale comes from a combination of state programs and home-grow legalization initiatives.
GrowBLOX Sciences Announces Patent Filings for Its Proprietary Process to Create Uniform Reproducible Cannabis Extracts
ACCESSWIRE - Tue Oct 13, 8:01AM CDT
GBLX Staying at the Forefront of Medical Cannabis Technology
GrowBLOX Sciences Announces First of Four Cultivation Labs Scheduled to Open in Las Vegas
ACCESSWIRE - Mon Sep 28, 8:02AM CDT
Expected to Open by End of Fourth Quarter; $10-12 Million Annual Revenue at Full Capacity at Just This Facility; Cutting-Edge Technological Growing of Medical Grade Cannabis
GrowBLOX Sciences Secures Four New Nevada State Medical Cannabis Licenses
ACCESSWIRE - Wed Sep 16, 8:01AM CDT
Continues to Accelerate its Plans for Significant Revenue Growth in 2016
GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General Manager
ACCESSWIRE - Tue Sep 08, 8:01AM CDT
Continues the Development of a Formidable GBLX Executive Team
GrowBLOX Sciences Appoints New CFO John Poss
ACCESSWIRE - Tue Aug 25, 7:30AM CDT
Creating a Formidable Executive Team
GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
GlobeNewswire - Thu Jul 23, 1:17PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced that over the course of the next few weeks certain changes in management personnel and operating procedures would soon be implemented in preparation for the commencement of cultivation operations through our majority-owned subsidiary, GB Sciences Nevada, LLC.
DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market
ACCESSWIRE - Thu Jul 16, 8:00AM CDT
WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.'s (OTCQB: GBLX) growing solutions to Medbox Inc.'s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.'s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.
These Cannabis Stocks Are Heating Up This Summer, 2015
ACCESSWIRE - Tue Jun 16, 3:07PM CDT
CORAL GABLES, FL / ACCESSWIRE / June 16, 2015 / More states are jumping on board the cannabis train and this industry has certainly begun to evolve since Colorado first came online as America's original legal state. Despite the recent uproar concerning the decision for business owners not to condone cannabis use (medical or otherwise), the market continues to take a liking to this industry because it is, in fact, just beginning to blossom. Aside from popular belief, this space isn't full of growers alone, there is an entire economy growing around the idea. Businesses are sprouting up with ideas from anything like cannabis vacation destinations to hemp infused beverages and anything in between. Companies like FBEC Worldwide (PINKSHEETS: FBEC), the Maryjane Group (OTCQB: MJMJ) and GrowBLOX Sciences, Inc. (OTCQB: GBLX) have all begun to see interest building around their novel concepts.
GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
GlobeNewswire - Mon Jun 15, 10:51AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced here today that it has received a $1.75 million funding commitment to enable GrowBLOX to complete construction and set-up operations at their MME Cultivation Facility in Las Vegas, Nevada. Pacific Leaf Ventures, LP has provided both the capital infusion and a license for their intellectual property including recognizable brand-names of cannabis and proprietary know-how for cultivation and cannabis extractions.
GrowBLOX Announces Deployment of Commercial Units
GlobeNewswire - Tue May 26, 12:29PM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the receipt of production-model GrowBLOX(TM) units for both GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR).
GROWBlox Sciences Takes Integrated Approach to Cannabis Medicine
ACCESSWIRE - Mon May 25, 7:36PM CDT
Untitled Document
GWPH: 83.28 (-0.88), GNC: 19.98 (+0.15), DGX: 84.91 (-0.27), NUTR: 25.46 (-0.05), LH: 138.05 (-0.66)
Growblox Announces Commercialization Initiative and Financing
GlobeNewswire - Wed May 13, 7:00AM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR"
, a majority-owned subsidiary domiciled in Puerto Rico. Growblox Sciences Announces Launch of New Corporate Website
GlobeNewswire - Mon May 11, 11:21AM CDT
Growblox Sciences Inc. (OTCQB:GBLX) ("Growblox" or the "Company"
, a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the launch of its new corporate website. 
